Related Experiment Video
Updated: Dec 6, 2025

10:39
Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
13.0K
Recombinant MG53 Protein Protects Mice from Lethal Influenza Virus Infection
Adam D Kenney1, Zhongguang Li1,2, Zehua Bian1
1The Ohio State University College of Medicine Columbus, Ohio and.
American Journal of Respiratory and Critical Care Medicine
|October 8, 2020
Abstract
No abstract available in PubMed .

